Generic drug sector developing
Links shared publicly online about this topic.
- 1,547total visits
Generic drug sector developing
View full resource at chinadaily.com.cn
Tags: Drug, Healthcare, Pharma, Novartis
Most Recently Shared on December 7, 2009 at 6:35 pm By:
RT @FiercePharma: China Daily: Generic drug sector developing. http://bit.ly/5qsGDE Sandoz has about 390 employees in China.
Roche to Cut Prices in India on Two Cancer Drugs - WSJ.com
online.wsj.com — “Roche is cutting the price of two expensive cancer drugs in India in an effort to gain market share and avoid competition from generic drugs in the fast-growing economy.” View full resource at online.wsj.com
Most Recently Shared on March 23, 2012 at 7:28 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
Roche Cuts Drug Prices in India http://t.co/bOfgCiQo via @WSJ
India Affirms Role as Developing World?s Pharmacy - IPS ipsnews.net
ipsnews.net — “By allowing a generic manufacturer to produce a patented cancer drug at a fraction of its current cost, India has declared that it is not about to abandon its role as the ?pharmacy of the world?s poor'.” View full resource at ipsnews.net
Most Recently Shared on March 19, 2012 at 4:53 pm By:
India Affirms Role as Developing World's Pharmacy #ibsa http://t.co/36372kiJ
Sanofi to close northeast England plant - Yahoo! News
news.yahoo.com — “From Yahoo! News: PARIS (Reuters) - French drugmaker Sanofi said on Thursday it plans to close a plant in northern England as it contends with European health spending cuts and growing competition from generic drugs. The Fawdon plant near Newcastle, which makes drugs including top-selling blood-thinner Plavix for the British and European markets, is expected to close by 2015 with a loss of around 450 jobs, a company spokesman said. Sanofi is reorganising some of its research and development and ” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 6:30 am By:
HealthTrendster Health Executive
Sanofi to close northeast England plant - PARIS (Reuters) - French drugmaker Sanofi said on Thursday it plans to clo... http://t.co/XBibNlvE
IGI Laboratories to Hold Conference Call for 4th Quarter 2011 Results | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based topical generic drug development and manufacturing company, will hold a conference call at 4:30 pm ET...” View full resource at bioportfolio.com
Most Recently Shared on March 9, 2012 at 8:55 pm By:
BioPF Dermatology Dermatology and Health News Feed
BioPortfolio News IGI Laboratories to Hold Conference Call for 4th Quarter 2011 Results: IGI L... http://t.co/Ugbdb4ju BioPortfolio News
National Center for Advancing Translational Sciences - National Institutes of Health (NIH)
ncats.nih.gov — “The National Institutes of Health (NIH) has established a new center, called the National Center for Advancing Translational Sciences (NCATS). Currently, many costly, time-consuming bottlenecks exist in the translational pipeline. Working in partnership with the public and private sectors, the Center will develop innovative ways to reduce, remove, or bypass these bottlenecks. This will speed the delivery of new drugs, diagnostics, and medical devices to patients.” View full resource at ncats.nih.gov
Most Recently Shared on February 27, 2012 at 6:38 pm By:
FasterCures Health Organization
Insel: #NCATS designed to complement - not compete - with private sector - http://t.co/yEPX5V9f
Amgen and Watson to Work Together on Generic Drugs - NYTimes.com
nytimes.com — “The two companies will develop and sell cheaper versions of several biologic cancer drugs.” View full resource at nytimes.com
Most Recently Shared on December 20, 2011 at 10:57 pm By:
Dr. P. D Tapp PhD, Doctor, and Health Executive
Amgen to team up with Watson Pharma to develop generic versions of best-selling drugs. http://t.co/gDuSWL9S
Amgen And Watson Join Forces To Develop Generic Cancer Drugs - Forbes
forbes.com — “Herceptin image via Wikipedia In a sign of the increasing hunger among drug giants to get in on the potentially lucrative market for copycats of expensive biotechnology drug, Amgen, the largest standalone biotechnology company, and generic firm Watson Pharmaceuticals will collaborate on developing copycate medicines for cancer. Under the terms of the [...]” View full resource at forbes.com
Most Recently Shared on December 20, 2011 at 1:48 am By:
blogaceutics Pharma and Health Communicator
Amgen And Watson Join Forces To Develop Generic Cancer Drugs [Forbes] http://t.co/2ghlglSb
Ranbaxy Laboratories Limited, India : Top Generic Pharmaceutical Company, Generic Drug Company India, Regulatory approvals, Pharmaceuticals brand
ranbaxy.com — “Pharma Investors, Pharma Financial Info of Ranbaxy, Ranbaxy is to provide value through pioneering work, research & development and quality pharmaceuticals across the globe.” View full resource at ranbaxy.com
Most Recently Shared on December 1, 2011 at 11:29 am By:
eyeonfda Pharma and Health Lawyer
Ranbaxy gets FDA approval to market Atorvastatin in US and launches - http://t.co/QoCp7rcC #cardio
Enbrel Patent Could Delay Generic Competition Until 2028 | Rheumatoid Arthritis Guy
rheumatoidarthritisguy.com — ““Amgen said Tuesday that a new patent had been granted that could protect its big-selling drug Enbrel from generic competition for 17 more years, a development…” View full resource at rheumatoidarthritisguy.com
Most Recently Shared on November 24, 2011 at 1:47 am By:
Enbrel Patent Could Delay Generic Competition Until 2028 http://t.co/4OmeavTa (via @GinaRClark) #rheum
Virtual platform for intellectual property sharing aims to speed development of drug treatments
news-medical.net — “"The World Intellectual Property Organization (WIPO) launched a consortium on Wednesday that would allow the public and private sector to share intellectual property to promote the development of new drugs to treat diseases such as malaria," Reuters reports.” View full resource at news-medical.net
Most Recently Shared on October 28, 2011 at 8:03 am By:
Virtual platform for intellectual property sharing aims to speed development of drug treatments: "The World Inte... http://t.co/KRJxKJR6
U.S. FDA guidance on biosimilars may be imminent - Yahoo! News
news.yahoo.com — “Read 'U.S. FDA guidance on biosimilars may be imminent' on Yahoo! News. NEW YORK (Reuters) - The U.S. Food and Drug Administration appears to be on the verge of issuing long-awaiting guidelines for the development of generic versions of complex biotechnology medicines.” View full resource at news.yahoo.com
Most Recently Shared on September 24, 2011 at 11:51 am By:
Dupage Family Medicine,
did his undergraduate training at the University of Notre Dame
and the University of Illinois at Urbana-Champaign, receiving a
Bachelor of Science degree in Biology from the University
of Illinois in 1990. He completed his medical education at
Southern Illinois University School of Medicine in 1994. His
residency trainingwas performed at Memorial Hospital, South Bend,
Indiana, after which he became board certified in Family
Practice in 1997.
Dr. Cunnar's clinical interests include pediatrics, diabetes,
and women's health. Other professional interests include clinical
research, in which he has participated as a principal
investigator in numerous studies.
Dr. Cunnar, his wife Sarah, and their children Ben, John and
Grayce reside in Aurora. In his free time, he enjoys his family,
all sports (especially golf and baseball), gardening and music." /> Jim Cunnar M.D. Active Health Library, Doctor, Family Medicine Doctor, and Physician
This issue is important, impacting all patients. U.S. FDA guidance on biosimilars imminent - http://t.co/CocmnYM2 #fb
Teva bets $7.5M on hep C program at upstart Cocrystal - FierceBiotech
fiercebiotech.com — “As the generic drug giant pushes to capitalize on more novel therapies, Teva Pharmaceutical ($TEVA) has invested an initial $7.5 million in Bothell, WA-based developer Cocrystal Discovery to advance Read more...” View full resource at fiercebiotech.com
Most Recently Shared on September 16, 2011 at 3:55 pm By:
John Carroll Health Communicator
Teva's been actively positioning itself behind strategic biotechs. Now Cocrystal (hep C) in Seattle. http://t.co/a045BxcE
generic drugs - Forum on Choosing Your Meds
thebody.com — “Generic medications have been in use in the developing world for several years (Brazil and India). Many of the pharmaceutical companies have negatiated deals to deliver the brand drugs to people in...” View full resource at thebody.com
Most Recently Shared on September 15, 2011 at 7:01 pm By:
Ask the HIV/AIDS Experts: "Which HIV Meds Are Due to Be Available in Generic Formulations in the U.S.?" http://t.co/Rexo5hGW #patent
Access to lifesaving generic medicines threatened by U.S. trade pact
news-medical.net — “"Access to affordable lifesaving medicines will be threatened where they are needed most -- in parts of the developing world -- if the U.S. insists on implementing restrictive intellectual property policies in the Trans-Pacific Partnership (TPP) trade agreement," states a press release from Doctors Without Borders.” View full resource at news-medical.net
Most Recently Shared on September 12, 2011 at 6:19 am By:
Access to lifesaving generic medicines threatened by U.S. trade pact: "Access to affordable lifesaving medicines... http://t.co/ZC5f9qo
Access to Lifesaving Generic Medicines Threatened by U.S. Trade Pact - The Body
thebody.com — “'Access to affordable lifesaving medicines will be threatened where they are needed most -- in parts of the developing world -- if the U.S. insists on ...” View full resource at thebody.com
Most Recently Shared on September 9, 2011 at 8:01 pm By:
Access to Lifesaving Generic Medicines Threatened by U.S. Trade Pact http://t.co/KtB6xaJ #hiv #aids #patents
Advertisement
